What early-stage investing reveals about biotech innovation
McKinsey Public & Social Sector Insights
DECEMBER 12, 2023
Public funding for biotech remains tenuous, but in 2022 and 2023 venture capitalists have continued to pour money into innovative platforms that could revolutionize the sector.
Let's personalize your content